CCM

Copernicus Capital Management Portfolio holdings

AUM $8.26M
1-Year Est. Return 37.91%
This Quarter Est. Return
1 Year Est. Return
+37.91%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.34M
AUM Growth
+$152K
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
21
New
Increased
Reduced
Closed

Top Buys

1
+$1.21M
2
+$778K
3
+$532K
4
TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
+$492K
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$468K

Top Sells

1
+$755K
2
+$710K
3
+$649K
4
RVMD icon
Revolution Medicines
RVMD
+$459K
5
RCKT icon
Rocket Pharmaceuticals
RCKT
+$355K

Sector Composition

1 Healthcare 91.36%
2 Industrials 5.99%
3 Consumer Staples 2.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTX icon
1
Vertex Pharmaceuticals
VRTX
$109B
$1.81M 28.62%
9,000
+6,000
FATE icon
2
Fate Therapeutics
FATE
$156M
$868K 13.69%
10,000
+2,000
ATRA icon
3
Atara Biotherapeutics
ATRA
$104M
$778K 12.27%
+2,000
ZNTL icon
4
Zentalis Pharmaceuticals
ZNTL
$108M
$532K 8.39%
+10,000
TCRR
5
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$492K 7.76%
+30,000
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$468K 7.38%
+5,000
ACCD
7
DELISTED
Accolade Inc
ACCD
$380K 5.99%
+7,000
JAZZ icon
8
Jazz Pharmaceuticals
JAZZ
$8.35B
$355K 5.6%
+2,000
GRTS
9
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$320K 5.05%
35,000
-2,000
SKIN icon
10
The Beauty Health Co
SKIN
$181M
$168K 2.65%
+10,000
RCUS icon
11
Arcus Biosciences
RCUS
$2.13B
$165K 2.6%
20,000
+10,000
REGN icon
12
Regeneron Pharmaceuticals
REGN
$68.5B
– –
-1,500
RVMD icon
13
Revolution Medicines
RVMD
$11B
– –
-10,000
TDOC icon
14
Teladoc Health
TDOC
$1.53B
– –
-1,500
TGTX icon
15
TG Therapeutics
TGTX
$5.52B
– –
-7,000
BCEL
16
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
– –
-18,000
ORTX
17
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
– –
-1,500
ABBV icon
18
AbbVie
ABBV
$385B
– –
-6,000
ARDX icon
19
Ardelyx
ARDX
$1.47B
– –
-50,000
BMRN icon
20
BioMarin Pharmaceuticals
BMRN
$10.3B
– –
-10,000
RCKT icon
21
Rocket Pharmaceuticals
RCKT
$407M
– –
-8,000